• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

GE cutoff hurts Star's annual results

Article

The termination of a CT component supply contract between StarTechnologies and GE Medical Systems has resulted in a major dropin revenues for Star. The Sterling, VA, company reported financialresults for fiscal 1996 (end-March) that indicated revenues

The termination of a CT component supply contract between StarTechnologies and GE Medical Systems has resulted in a major dropin revenues for Star. The Sterling, VA, company reported financialresults for fiscal 1996 (end-March) that indicated revenues of$4.3 million, compared with $21.6 million the year before, whenthe agreement was still in effect. Star posted a loss of $4 millionfor the year, compared with net income of $1.2 million in 1995.

Star had been supplying GE with CT image reconstruction processorsuntil early 1995, when GE terminated the relationship. A disputebetween the companies went to an arbitration panel, which awardedStar $9.1 million (SCAN 3/27/96). GE is trying to have the rulingoverturned.

Star CEO Robert Compton said that 1996 was a transitional yearfor the company. The firm downsized in June 1995 and has beenworking with an investment banking firm to examine strategic opportunities,including acquisitions. It is also working to bring a new lineof image management products to market.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.